4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-22-067099
Chief Executive Officer bought 30,000 shares at an average $1.85 ($55,383)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudley Robert Michael Chief Executive Officer | 2022-05-27 | Purchase | +28,000 | $1.84 | $51,643 | 871,114 | D |
| Dudley Robert Michael Chief Executive Officer | 2022-05-31 | Purchase | +2,000 | $1.87 | $3,740 | 873,114 | D |
| Open-market purchases · 30,000 sh · avg $1.85 · $55,383 | |||||||
Loading xslF345X03/tm2217388-1_4seq1.xml…